| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.76 | 0.004 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |